IMGG: Imaging3 CEO is upset
That the mean people won't let him post hype on Facebook and IHub anymore (CEO has an iHub account)
IMGG .10 (.03 - $1.95 during last private placement)
IMGG will demonstrate it's 3d X-ray device on MoneyTV Fri 13 May even though the FDA rejected it's approval application.
IMGG last week was forced by it's FDA legal counsel to admit their FDA legal counsel stepped down in February.
The Letter to Shareholders can be found at this link www.imaging3.com/news/newsletters/news_may4_11.html.
--------------------------------------------------------------
• May 2011
Dear Shareholder,
I understand the current environment and situation of Imaging3 seems frustrating as the share price has eroded over the last year and a half. There has been a great deal of speculation and discontent regarding this company, its product and myself personally. This situation may seem more frustrating as the company has had to pull back from its Investor Relations communications efforts. This is due in large part to a very aggressive negative element that seem to be determined to corrupt any attempt by Imaging3 to communicate directly with its shareholder base. This effort has been so successful it has literally tied our hands in how and what we can communicate with our shareholders. Management’s naivety in this regard may have fostered this current environment of insatiable entitlement of information. As every attempt to provide more information in the form of forums, conference calls and access to Investor Relations via phone or email has created an increasing demand of information. This increase has created an environment where our Investor Relations contact, Mike Nessen, has become overwhelmed and unable to perform any other duties within the company.
Effective immediately I have removed Mike Nessen from the responsibility and position of Investor Relations contact. Though he has done a remarkable job, he is needed to assist myself and our consultants with preparing our FDA submission. I ask you to be patient as we work to hire an Investor Relations/Public Relations firm to assist us with our corporate communications. In the meantime all communications from the company will be in the form of a press release, newsletter, Money TV appearances or SEC filings. Once we have found a suitable company to assist us with our corporate communications we will announce this via press release and newsletter.
I want to assure you that management here at Imaging3 is still very committed to getting our product FDA approved. We recently announced a change in legal representation, in an 8K filing with the SEC, which actually occurred back in February and early March. This was only recently communicated as directed by our formal consultants desire to correct the public record. Nothing has changed as we have hired replacement FDA legal counsel as well as FDA technical consultants with a potential third consulting group being considered to assist the company with performing the imaging review. These consultants all have extensive experience and depth of knowledge to assist Imaging3 with our strategy and goal of achieving FDA approval.
Imaging3 along with our consultants are working very hard to file our re-submission 510(k) with the FDA as soon as possible. As I addressed in a Money TV appearance on April 8th, 2011 we have broken down this process into three milestones. First we will prepare for a meeting with the FDA to address our protocols and our 510(k) submission to agree on protocols for acquiring and reviewing comparative imagery. Secondly we will meet with the FDA to discuss and come to an agreement on protocols to acquire and review these images. Lastly we will acquire and review these images using the agreed upon protocols and include them with our submission and file. We are currently working to complete our preparations to meet with the FDA and will report once we have completed that meeting.
I am currently working on creating a video demonstration of the “proof of concept” of 3D real time imaging to be aired on Money TV. This is scheduled for taping during an interview on Money TV on Thursday May 12, 2011, which will be available for viewing via the internet on Friday May 13, 2011 and aired on local channels sometime afterwards. We are working with our consulting groups to create a video demonstration that will not negatively impact our 510(k) submission or create any issues with the FDA in general.
In closing I’d like to each of you to use caution when receiving information from outside sources, specifically the internet. I ask that you first and foremost consider the source. It’s easy to have an opinion after the fact, especially when you can maintain anonymity. Ask yourself or more importantly ask the person providing the opinion, rumor or speculation, what experience and qualifications do they have to make such a claim. What is their agenda and back ground. I think you will find that most if not all will continue to hide in anonymity than be scrutinized.
It has been a long road towards FDA approval and I appreciate those of you who have continued to support Imaging3. Though I can never “guarantee” approval, we are working very hard towards that end. Success is the best way to silence our critics.
Sincerely,
Dean Janes
Chairman/CEO
Imaging3, Inc.
Burbank CA 91505
(800) 900-9729
www.imaging3.com |
